Suppr超能文献

通过多层切片对乳腺癌前哨和非前哨腋窝淋巴结进行组织学评估及非前哨转移的预测因素

Histologic evaluation of sentinel and non-sentinel axillary lymph nodes in breast cancer by multilevel sectioning and predictors of non-sentinel metastasis.

作者信息

Jeeravongpanich Piyarat, Chuangsuwanich Tuenjai, Komoltri Chulaluk, Ratanawichitrasin Adune

机构信息

1 Pathology Unit, Songkhla Hospital, Songkhla 90000, Thailand ; 2 Department of Pathology, 3 Office for Research and Development, 4 Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.

出版信息

Gland Surg. 2014 Feb;3(1):2-13. doi: 10.3978/j.issn.2227-684X.2014.02.01.

Abstract

Sentinel lymph node (SLN) provides accurate nodal staging for breast cancer. This technique has been introduced in Siriraj Hospital since 1998. The goal of this study is to assess its accuracy in predicting the state of the axilla, and compare the results of standard examination and multilevel sectioning. A retrospective analysis of 195 breast cancer patients who underwent both SLN biopsy (using dye alone as the lymphatic mapping) and axillary node dissection during 1998-2002 were analyzed. All slides including SLNs and the non-SLNs (NSLNs) were reviewed and multilevel study was performed on all SLNs and NSLNs [four levels of hematoxylin-eosin (HE) at 200 µm interval and keratin stains on the first and fourth levels]. Of 195 patients, 30% of cases were SLN-positive (32 NSLN-positive and 27 NSLN-negative). Additional study could detect positive axillary nodes 10.8% (4 SLN-positive and 5 NSLN-positive) more than standard HE stain. The false negative rate increased from 20.3% to 24.1%. The concordance between SLN and NSLN statuses was 89.7%. The sensitivity was 75.9%. By multivariate analysis, the significant predictors for axillary node metastasis were tumor size of more than 2.2 cm, histologic type of invasive ductal carcinoma (IDC), not otherwise specified (NOS) and lymphovascular invasion (LVI). By univariable analysis, the significant predictors of NSLN metastasis after positive-SLN were outer location of the tumor, LVI and perinodal extension. In conclusion, use of multilevel and immunohistochemistry increased detection of positive-SLNs. Caution should be kept in accepting SLN biopsy using peritumoral dye technique alone as the procedure for staging due to a high false-negative rate. The concordance rate of 89.7% confirmed the reliability of SLN. Outer location of tumor, LVI and perinodal extension is significant predictors of positive-NSLN after positive-SLN.

摘要

前哨淋巴结(SLN)可为乳腺癌提供准确的淋巴结分期。自1998年起,该技术已在诗里拉吉医院引入。本研究的目的是评估其预测腋窝状态的准确性,并比较标准检查和多层切片的结果。对1998年至2002年间接受SLN活检(仅使用染料进行淋巴绘图)和腋窝淋巴结清扫的195例乳腺癌患者进行回顾性分析。对包括SLN和非SLN(NSLN)在内的所有切片进行复查,并对所有SLN和NSLN进行多层研究[苏木精-伊红(HE)染色,间隔200 µm共四层,第一层和第四层进行角蛋白染色]。195例患者中,30%的病例SLN阳性(32例NSLN阳性和27例NSLN阴性)。额外检查比标准HE染色能多检测出10.8%的腋窝阳性淋巴结(4例SLN阳性和5例NSLN阳性)。假阴性率从20.3%增加到24.1%。SLN和NSLN状态之间的一致性为89.7%。敏感性为75.9%。多因素分析显示,腋窝淋巴结转移的显著预测因素为肿瘤大小超过2.2 cm、未特殊说明的浸润性导管癌(IDC)组织学类型以及淋巴管侵犯(LVI)。单因素分析显示,SLN阳性后NSLN转移的显著预测因素为肿瘤外侧位置、LVI和结周扩展。总之,多层检查和免疫组化可增加SLN阳性的检出率。由于假阴性率较高,仅使用肿瘤周围染料技术进行SLN活检作为分期方法时应谨慎。89.7%的一致性率证实了SLN的可靠性。肿瘤外侧位置、LVI和结周扩展是SLN阳性后NSLN阳性的显著预测因素。

相似文献

3
Predictors of non-sentinel lymph node metastasis in breast cancer patients.
Eur J Cancer. 2004 Jul;40(11):1731-7. doi: 10.1016/j.ejca.2004.04.006.
4
Prediction of non-sentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node.
Breast. 2014 Aug;23(4):453-9. doi: 10.1016/j.breast.2014.03.009. Epub 2014 Apr 24.
5
Positive non-sentinel axillary lymph nodes in breast cancer with 1-2 sentinel lymph node metastases.
Medicine (Baltimore). 2018 Nov;97(44):e13015. doi: 10.1097/MD.0000000000013015.
6
Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery.
Breast J. 2004 Sep-Oct;10(5):392-7. doi: 10.1111/j.1075-122X.2004.21446.x.
8
[A nomogram to predict non-sentinel lymph node metastasis for breast cancer patients with positive axillary sentinel lymph node].
Zhonghua Zhong Liu Za Zhi. 2020 Aug 23;42(8):653-659. doi: 10.3760/cma.j.cn112152-20190824-00545.
9
Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.
Breast J. 2003 May-Jun;9(3):153-62. doi: 10.1046/j.1524-4741.2003.09304.x.
10
Risk factors of non-sentinel lymph node metastasis in 443 breast cancer patients with sentinel lymph node-positive.
Medicine (Baltimore). 2022 Jul 22;101(29):e29286. doi: 10.1097/MD.0000000000029286.

引用本文的文献

1
Prediction of axillary lymph node metastasis in T1 breast cancer using diffuse optical tomography, strain elastography and molecular markers.
Quant Imaging Med Surg. 2025 Mar 3;15(3):2162-2174. doi: 10.21037/qims-24-1664. Epub 2025 Feb 26.
2
Intraoperative spectroscopic evaluation of sentinel lymph nodes in breast cancer surgery.
Breast Cancer Res Treat. 2024 Aug;207(1):223-232. doi: 10.1007/s10549-024-07349-z. Epub 2024 May 20.

本文引用的文献

1
Pathologic examination of sentinel lymph nodes from melanoma patients.
Semin Diagn Pathol. 2008 May;25(2):100-11. doi: 10.1053/j.semdp.2008.04.002.
2
Histopathologic examination of the sentinel lymph nodes.
Breast J. 2006 Sep-Oct;12(5 Suppl 2):S152-6. doi: 10.1111/j.1075-122X.2006.00336.x.
3
Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual.
CA Cancer J Clin. 2006 Jan-Feb;56(1):37-47; quiz 50-1. doi: 10.3322/canjclin.56.1.37.
4
Accuracy and reliability of sentinel node biopsy in patients with breast cancer. Single centre study with long term follow-up.
Breast Cancer Res Treat. 2006 Jan;95(2):111-6. doi: 10.1007/s10549-005-9052-4. Epub 2005 Oct 22.
5
Comparison of blue dye and isotope with blue dye alone in breast sentinel node biopsy.
ANZ J Surg. 2005 Sep;75(9):817-21. doi: 10.1111/j.1445-2197.2005.03531.x.
8
Sentinel lymph node micrometastasis as a predictor of axillary tumor burden.
Breast J. 2004 Mar-Apr;10(2):101-5. doi: 10.1111/j.1075-122x.2004.21280.x.
10
Sentinel lymph node evaluation for tumor metastasis.
Semin Diagn Pathol. 2002 Nov;19(4):263-77.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验